Trial Profile
Effect of natalizumab treatment on anti-JC Virus Ab seropositivity using Longitudinal approach.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2016
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 04 Nov 2016 New trial record